220 related articles for article (PubMed ID: 12210630)
1. Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes.
Curtin F; Elbourne D; Altman DG
Stat Med; 2002 Aug; 21(15):2145-59. PubMed ID: 12210630
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carry-over.
Curtin F; Elbourne D; Altman DG
Stat Med; 2002 Aug; 21(15):2161-73. PubMed ID: 12210631
[TBL] [Abstract][Full Text] [Related]
3. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data.
Sweeting MJ; Sutton AJ; Lambert PC
Stat Med; 2004 May; 23(9):1351-75. PubMed ID: 15116347
[TBL] [Abstract][Full Text] [Related]
4. Evidence from crossover trials: empirical evaluation and comparison against parallel arm trials.
Lathyris DN; Trikalinos TA; Ioannidis JP
Int J Epidemiol; 2007 Apr; 36(2):422-30. PubMed ID: 17301102
[TBL] [Abstract][Full Text] [Related]
5. One relative risk versus two odds ratios: implications for meta-analyses involving paired and unpaired binary data.
Zou GY
Clin Trials; 2007; 4(1):25-31. PubMed ID: 17327243
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes.
Curtin F; Altman DG; Elbourne D
Stat Med; 2002 Aug; 21(15):2131-44. PubMed ID: 12210629
[TBL] [Abstract][Full Text] [Related]
7. HGLM versus conditional estimators for the analysis of clustered binary data.
Kang W; Lee MS; Lee Y
Stat Med; 2005 Mar; 24(5):741-52. PubMed ID: 15696505
[TBL] [Abstract][Full Text] [Related]
8. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events.
Bradburn MJ; Deeks JJ; Berlin JA; Russell Localio A
Stat Med; 2007 Jan; 26(1):53-77. PubMed ID: 16596572
[TBL] [Abstract][Full Text] [Related]
9. A method for the meta-analysis of mutually exclusive binary outcomes.
Trikalinos TA; Olkin I
Stat Med; 2008 Sep; 27(21):4279-300. PubMed ID: 18416445
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of controlled trials of anticoagulant therapies in patients with sepsis.
Macias WL; Sasheygi A; Xu D; Freeman BD
Shock; 2003 Dec; 20(6):582-3; author reply 583-4. PubMed ID: 14625485
[No Abstract] [Full Text] [Related]
11. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.
Dahabreh IJ; Economopoulos K
Clin Trials; 2008; 5(2):116-20. PubMed ID: 18375649
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of community-based cluster randomization trials with binary outcomes.
Darlington GA; Donner A
Clin Trials; 2007; 4(5):491-8. PubMed ID: 17942465
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
Jones AP; Riley RD; Williamson PR; Whitehead A
Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930
[TBL] [Abstract][Full Text] [Related]
14. Imputing variance estimates do not alter the conclusions of a meta-analysis with continuous outcomes: a case study of changes in renal function after living kidney donation.
Thiessen Philbrook H; Barrowman N; Garg AX
J Clin Epidemiol; 2007 Mar; 60(3):228-40. PubMed ID: 17292016
[TBL] [Abstract][Full Text] [Related]
15. Conditional power calculations for clinical trials with historical controls.
Korn EL; Freidlin B
Stat Med; 2006 Sep; 25(17):2922-31. PubMed ID: 16479548
[TBL] [Abstract][Full Text] [Related]
16. Efficiency of the cross-over design: an empirical estimation.
Garcia R; Benet M; Arnau C; Cobo E
Stat Med; 2004 Dec; 23(24):3773-80. PubMed ID: 15580599
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of summary survival curve data.
Arends LR; Hunink MG; Stijnen T
Stat Med; 2008 Sep; 27(22):4381-96. PubMed ID: 18465839
[TBL] [Abstract][Full Text] [Related]
18. Improved Fisher z estimators for univariate random-effects meta-analysis of correlations.
Hafdahl AR
Br J Math Stat Psychol; 2009 May; 62(Pt 2):233-61. PubMed ID: 18257972
[TBL] [Abstract][Full Text] [Related]
19. A method for combining matched and unmatched binary data. Application to randomized, controlled trials of photocoagulation in the treatment of diabetic retinopathy.
Duffy SW; Rohan TE; Altman DG
Am J Epidemiol; 1989 Aug; 130(2):371-8. PubMed ID: 2750732
[TBL] [Abstract][Full Text] [Related]
20. Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells.
Rücker G; Schwarzer G; Carpenter J; Olkin I
Stat Med; 2009 Feb; 28(5):721-38. PubMed ID: 19072749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
